|
|
Opening Session
|
|
Welcome Address by the Organizers
Jacques Repussard, IRSN/France, Gilles Bloch, CEA/France
|
|
Welcome Address by the MELODI Governing Board
Wolfgang Weiss, BfS/Germany
|
|
Welcome Address by the European Commission
Octavio Quintana Trias, EC; represented by André Jouve |
|
Welcome Address by the WHO
Maria del Rozario Perez , WHO
|
|
Toxicology of the 21st century
Melvin E Andersen, the Hamner Institutes for Health sciences/USA
|
|
Genetic Approaches in Radiation-Induced Cancer
Marc Lathrop, CEA/France
|
|
Challenges of Low Dose Exposure in Medical Uses of Ionising Radiation
Klaus Rüdiger Trott, Andrea Ottolenghi, Vere Smyth, University Degli Studi, Pavia/Italy
|
|
|
Open Plenary Session 1: Non Cancer Effects
|
|
Lens Opacities
Jochen Graw, Helmholtz Center Munich/Germany |
|
The Epidemiology and Radiobiology of Cardiovascular Diseases
Marc Little, National Cancer Institute (NCI)/USA
|
|
|
Low Dose Effects of Toxic Metal Compounds
Andrea Hartwig, Karlsruhe Institute of Technology/Germany |
|
|
Effects of Low Dose in Immune System
Benoît Favier, CEA/France |
|
|
Open Plenary Session 2: Individual Radiation Sensitivity for Cancer
|
|
|
The Impact of DNA Damage on Human Health
Jan H.J. Hoeijmakers, Erasmus Medical Center, Rotterdam/the Netherlands |
|
|
Individual Sensitivity for Radiation-Induced Cancer
Janet Hall, Institut Curie, Inserm/France |
|
|
Genetic Susceptibility of Radiation-Related Thyroid Cancer
Fumihiko Matsuda, Kyoto University/Japan |
|
|
Individual Susceptibility and Clinical Reality
Jacques Balosso, CHU Grenoble/France |
|
|
Open Plenary Session 3: Effects of Radiation Quality
|
|
|
Innovative Ultrafast Radiation Sources: Towards the Real-Time Nanodosimetry
Yann Gauduel, ENS/Inserm, France |
|
|
Non-Targeted Dose Response Models and Space Travel
Francis A. Cucinotta, NASA/USA |
|
|
Risk Associated to Uranium Exposure
Irina Canu, IRSN/France |
|
Radiation Qualities in Carbon-Ion Radiotherapy at NIRS/HIMAC
Shunsuke Yonai, NIRS/Japan |
|
|
Reporting and Plenary Discussion Session
|
|
Risks Associated to Uses of Ionizing Radiation for Medical Applications, Including
Diagnosis and Therapy Procedures
François Paris, Inserm/France |
|
Biomarkers or Radiosensitivity
Penny Jeggo, University of Sussex/UK |
|
Biological Effects Resulting from an Internal Contamination
with Low Dose of Radionuclides (Cancer and Non-Cancer Effects)
Isabelle Dublineau, IRSN/France |
|
Cell-Interactions Mediating Radiation Responses and Carcinogenesis
Mary Helen Barcellos-Hoff, New York Langone Medical Center/USA |
|
Stem Cells, Tissue Turnover and Low Doses
Ohtsura Niwa, BioMedics Japan Inc./Japan |
|
|
Brain/Neuronal Cell - Radiation Effects
Per Eriksson, Uppsala University/Sweden |
|
|
Strategic Research Agenda - Plenary Session
|
|
Report from the MELODI SRA Expert Group
Dietrich Averbeck, David Lloyd, Peter O'Neill |
|
Conclusion
Wolfgang Weiss, BfS/Germany |